¼ÓÈëVIP ÉÏ´«¿¼²©×ÊÁÏ ÄúµÄÁ÷Á¿ Ôö¼ÓÁ÷Á¿ ¿¼²©±¨°à ÿÈÕÇ©µ½
   
Ö÷Ìâ : Ò»¾Å¾Å¾ÅÄ격ʿÉúÈëѧ¿¼ÊÔÊÔÌâ(רҵ»ù´¡: ÃâÒßѧ)
¼¶±ð: ×ܰæÖ÷
ÏÔʾÓû§ÐÅÏ¢ 
Â¥Ö÷  ·¢±íÓÚ: 2007-01-25   

Ò»¾Å¾Å¾ÅÄ격ʿÉúÈëѧ¿¼ÊÔÊÔÌâ(רҵ»ù´¡: ÃâÒßѧ)

Ò»¾Å¾Å°ËÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÊÔÌâ O|0,= 5  
0Q:l,\lY  
£¨ÃâÒßѧרҵºÍרҵ»ù´¡£© ;1Q @d  
?2Sm f  
Ò».Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£© 4siq  
/3qKsv#  
1.Co-stimulators (or co-stimulating molecules) G5!!^p~  
j%fi*2uX  
2.NK-kB fWl #CI\]  
{6HgKI  
3.Immunoglobulin superfamily \kC'y9k  
7$Pf  
4.antigen-presenting cell (APC) ZEG~ek=jM  
XiAflO  
5.death domain xgZ<. r  
OA&r8WK3  
6.CCR and CXCR 9K=K,6 b  
k3& /Ei5  
7.Lectin (or mitogen) HnY.=_G  
\N)!]jq  
8.Clusters of differentiation, CD) >\!k~Zi  
!r9~K^EI  
9.B7 family gyOAvx  
a #+;BH 1  
10.Cytotoxic T lymphocyte, CTL) mN'sJ1L-  
8n/[oDc]  
11.IL-15 and IL-15 receptor (IL-15R) =Kt!+^\")  
5)p!}hWs  
12.MHC restriction r-&* `Jh  
b:x*Hjf  
13.Affinity-chromatography $QaEU="Z  
G+K`FUNA  
14.Cyctosprin A, CsA 'o1lJ?~kH  
d @ tD0s  
15.Antibody-dependent cell-mediated cytotoxicity, ADCC) /!W',9ua6  
|O[ I=!  
¶þ.ÎÊ´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£© &8hW~G>(m  
@Pf['BF"  
1.ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿 ! Y' ~?BI  
AnQUdU  
2.ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØÏµ¡£ pwo @ S"  
p ?x]|`M  
3.ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢½á¹¹¼°Æäʶ±ð ¿¹Ô­µÄÌØµã¡£ #Z}YQ $g  
aY\(R02B  
Èý.Ñ¡ÔñÎÊ´ðÌ⣨¸÷רҵ¿¼ÉúÖ»´ðÒ»µÀ±¾×¨ÒµÊÔÌ⣬25·Ö£© <Mf(2`T  
?cgb3^R'  
ÃâÒßѧרҵ£º ! $fF3^8-  
)D ':bWP  
1.ÊÔÊöB7/CD28, CTLA-4£¬CD40/CD40L£¬LFA-1/ICAM-1£¬CD2/LFA-3µÄ½á¹¹¡¢·Ö²¼ÒÔ¼°Ï໥×÷Óúó½éµ¼µÄÖ÷ÒªÉúÎïѧ¹¦ÄÜ¡£ Ol*|J  
&e5,\TQ  
Ïû»¯ÄÚ¿Æ£º DC*6=m_  
>!#or- C  
2.Ö×Áö¿¹Ô­·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£ ]wV_xZ)l^A  
+aRHM H  
ѪҺ²¡Ñ§×¨Òµ£º &dJ\}O[r  
n;~6'f xe  
3.ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎÎªÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔ­Òò£¨Ìõ¼þ£©ÊÇʲô£¿
ÆÀ¼ÛÒ»ÏÂÄãä¯ÀÀ´ËÌû×ӵĸÐÊÜ

¾«²Ê

¸Ð¶¯

¸ãЦ

¿ªÐÄ

·ßÅ­

ÎÞÁÄ

¹àË®

  
ÃèÊö
¿ìËٻظ´

ÑéÖ¤ÎÊÌâ:
Ãâ·Ñ¿¼²©ÂÛÌ³ÍøÖ·ÊÇʲô? ÕýÈ·´ð°¸:freekaobo.com
°´"Ctrl+Enter"Ö±½ÓÌá½»